CHAMPIONS ONCOLOGY, INC. (CSBR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue Annual

0 3.5M 7M 10.5M FY17: 3.3M FY18: 2.6M FY19: 3.1M FY20: 4.2M FY21: 5.5M FY22: 6.4M FY23: 7M FY24: 7.1M FY25: 7.5M FY26: 9.3M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Gross Profit Annual

-24M -16M -8M 0 8M 16M 24M FY20: -12.8M FY21: -15.9M FY22: -17.3M FY23: -22.5M FY24: -22.3M FY25: -20.8M FY26: -21.6M FY20 FY21 FY22 FY23 FY24 FY25 FY26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-9M -6M -3M 0 3M 6M 9M FY17: -6.8M FY18: -1.4M FY19: 270K FY20: -1.9M FY21: 366K FY22: 607K FY23: -5.3M FY24: -7.4M FY25: 4.6M FY26: -1.1M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Net Income Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M FY17: -6.9M FY18: -1.5M FY19: 128K FY20: -2.1M FY21: 362K FY22: 548K FY23: -5.3M FY24: -7.3M FY25: 4.7M FY26: -1.2M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Cost of Revenue Annual

0 15M 30M 45M FY20: 17M FY21: 21.4M FY22: 23.6M FY23: 29.5M FY24: 29.4M FY25: 28.4M FY26: 30.9M FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating Cash Flow Annual

-9M -6M -3M 0 3M 6M 9M FY17: -2.8M FY18: -1.2M FY19: 1.9M FY20: 2.9M FY21: -1.7M FY22: 6.5M FY23: 4M FY24: -6.1M FY25: 7.4M FY26: -4.5M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Free Cash Flow Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M FY17: -3.6M FY18: -2.5M FY19: 1M FY20: 685K FY21: -5M FY22: 4.1M FY23: 1.1M FY24: -7M FY25: 7M FY26: -5M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 5M 10M 15M FY16: 8.7M FY18: 11M FY19: 14.1M FY20: 11.8M FY21: 14.6M FY22: 14.2M FY23: 13.5M FY24: 13.5M FY25: 14.3M FY26: 13.8M FY16 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q1 '14: -0.12 Q2 '14: -0.11 Q3 '14: -0.11 Q4 '14: -0.11 Q1 '15: -0.72 Q2 '15: -1.34 Q3 '15: -1.93 Q4 '15: -2.16 Q1 '16: -1.85 Q2 '16: -1.49 Q3 '16: -1.16 Q4 '16: -1.20 Q1 '17: -1.13 Q2 '17: -0.89 Q3 '17: -0.74 Q4 '17: -0.64 Q1 '18: -0.44 Q2 '18: -0.40 Q3 '18: -0.28 Q4 '18: -0.13 Q1 '19: -0.03 Q2 '19: -0.00 Q3 '19: -0.02 Q4 '19: 0.01 Q1 '20: -0.09 Q2 '20: -0.09 Q3 '21: -0.11 Q4 '22: 0.04 Q1 '23: 0.03 Q2 '23: 0.01 Q3 '23: -0.22 Q4 '23: -0.39 Q1 '24: -0.56 Q2 '24: -0.71 Q3 '24: -0.72 Q4 '24: -0.54 Q1 '25: -0.26 Q2 '25: -0.06 Q3 '25: 0.44 Q4 '26: -0.07 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '23 Q3 '24 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.